With the introduction of FDA Modernization Act in 2021, the use of animal models for preclinical testing is being discouraged in the pharmaceutical industry.

Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses.

By 2035, the financial opportunity within the organ-on-chip market has been analyzed across the following segments:

  • Type of Product
  • Organ(s) based
  • Disease(s) based
  • Type of Application Area
  • Drug Discovery and Toxicity Testing
  • Cancer Research
  • Tissue Engineering and Regenerative Medicine
  • Stem Cell Research
  • Purpose
  • Research Use
  • Therapy Development
  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

The “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” 2022-2035” report features the following companies, which we identified to be key players in this domain:

  • BEOnChip
  • Dynamic42
  • Emulate
  • SynVivo
  • TissUse
  • uFluidix

Table of Contents

  1. Preface
  • Executive Summary
  • Introduction
  1. Organ-on-Chip: Market Landscape
  • Organ-on-Chip Developers: Company Profiles
  • Patent Analysis
  • Brand Positioning Matrix
  • Academic Grants Analysis
  • Partnerships and Collaborations
  • Funding and Investment Analysis
  • Case Study: Scaffold-Free 3D Cell Culture Systems
  • Organ-on-Chip: Market Forecast and Opportunity Analysis
  1. Conclusion

14. Executive Insights



To view more details on this report, click on the link


You may also be interested in the following titles:

Blockchain Technology in Healthcare Market 
Long-Acting Drug Delivery Technologies and Services Market

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.


Ben Johnson

+1 (415) 800 3415

[email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *